White Papers
-
Optimizing Generative AI In Clinical Operations
4/17/2024
Crafting a thoughtful strategy to determine the optimal utilization of Generative AI in advancing medical research and enhancing patient well-being.
-
Patient-Defined Recruitment: The Movement Advanced By COVID-19
4/17/2024
The pandemic forced the pharmaceutical industry to reimagine how we recruit patients to clinical trials – and it's delivering significant benefits to sponsors who embrace these changes.
-
How Clinical Trial Design Impacts Enrollment Of Diverse Populations
4/17/2024
Discover the latest findings revealing crucial insights into the factors influencing participants' engagement in clinical trials, offering valuable knowledge about the diverse perspectives and considerations driving participation decisions.
-
Insights: Global Patient Views And Engagement In Clinical Trials
4/15/2024
Enhancing the patient journey within clinical trials begins with engaging participants to understand their needs and preferences, ensuring they enroll and remain committed throughout the study.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
4/10/2024
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Cystic Fibrosis: Global Clinical Trial Landscape (2024)
4/8/2024
Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
4/8/2024
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Digital Biomarker Upholds Adherence, User Satisfaction, Validity
3/25/2024
Clinical outcome assessments can present challenges in clinical trials. Discover how this solution is able to utilize digital biomarkers to identify and measure clinically relevant signals in neurological conditions.
-
Digital Endpoint Resource Guide: Rheumatology
3/19/2024
Explore how wearables and sensor-based technologies provide continuous, remote patient-centered outcomes, reducing trial participation burdens, increasing success probabilities, and enhancing condition management.
-
Achieving Statistical Significance With Limited Patient Populations
3/15/2024
Explore highlights from a timely panel debate on emerging approaches to clinical research and data collection for advanced, novel and personalized therapies, especially linked to rare diseases.